Pharsight

Drugs that contain Calcium Acetate

1. Phoslyra patents expiration

PHOSLYRA Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8592480 FRESENIUS MEDCL Liquid compositions of calcium acetate
Jul, 2027

(3 years from now)

US9089528 FRESENIUS MEDCL Liquid compositions of calcium acetate
Jul, 2027

(3 years from now)

US8591938 FRESENIUS MEDCL Liquid compositions of calcium acetate
Feb, 2030

(5 years from now)

Market Authorisation Date: 18 April, 2011

Treatment: Use of phoslyra for reduction of serum phosphorous in patients

Dosage: SOLUTION;ORAL

How can I launch a generic of PHOSLYRA before it's drug patent expiration?
More Information on Dosage

PHOSLYRA family patents

Family Patents